Management challenges in patients with comorbid COVID-19 associated delirium and serious mental illness - A case series.
Int J Psychiatry Med
; 56(4): 255-265, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1058157
ABSTRACT
BACKGROUND:
There is still a lot unknown about the novel Coronavirus Disease 19 (COVID-19) and its effects in humans. This pandemic has posed several challenging clinical situations to healthcare providers.OBJECTIVE:
We hope to highlight the distinctive challenges that COVID-19 presents in patients with serious mental illness and what steps primary medical teams can take to co-manage these patients with the psychiatry consultants.METHODS:
We present a retrospective chart review of four patients who were on psychotropic polypharmacy and admitted to our hospital from the same long-term psychiatric facility with COVID-19 delirium and other associated medical complications.RESULTS:
We illustrate how the primary medical teams and psychiatrists collaborated in clinical diagnosis, treatment, and management.CONCLUSIONS:
Patients with serious mental illness and COVID-19 infection require active collaboration between primary medical teams and psychiatrists for diagnostic clarification, reduction of psychotropic polypharmacy to avoid adverse effects and drug-drug interactions, prevention of psychiatric decompensation, and active management of agitation while balancing staff and patient safety concerns.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Psychotic Disorders
/
Schizophrenia
/
Bipolar Disorder
/
Delirium
/
COVID-19
Type of study:
Case report
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Int J Psychiatry Med
Year:
2021
Document Type:
Article
Affiliation country:
0091217420985979
Similar
MEDLINE
...
LILACS
LIS